SCHEDULES

Valid from 19/07/2006

SCHEDULE 2 U.K. Relief for research and development: subjects of clinical trials

Amendments to Schedule 13 to FA 2002 U.K.

3 (1) Schedule 13 to FA 2002 (tax relief for expenditure on vaccine research etc) is amended as follows. U.K.

(2) In paragraph 3 (qualifying expenditure on direct research and development), in sub-paragraph (5)—

(a) omit the word “or” at the end of paragraph (b);

(b) after that paragraph insert—

“(ba) is incurred on relevant payments to the subjects of a clinical trial, or”.

(3) In paragraph 5 (which applies certain definitions from Schedule 20 to FA 2000)—

(a) in the heading, after “ “software or consumable items”,” insert “ “relevant payments to the subjects of a clinical trial”, ”;

(b) in sub-paragraph (3), after paragraph (c) insert—

“(ca) paragraph 6A (relevant payments to subjects of clinical trials);”.

(4) In paragraph 9 (relevant expenditure of the sub-contractor), in sub-paragraph (3)—

(a) omit the word “or” at the end of paragraph (b);

(b) after that paragraph insert—

“(ba) is incurred on relevant payments to the subjects of a clinical trial, or”.